Cadence Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cadence Capital Management's BIIB Position: Q3 2019 in Review
Cadence Capital Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 981 shares — an estimated $229K sold.
Cadence Capital Management first reported a position in BIIB in Q4 2014 and held it in 19 quarters. The position peaked at $3.28M in Q3 2016. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.
- Cadence Capital Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
- Cadence Capital Management sold 981 Biogen shares in Q3 2019, an estimated $229K.
- Cadence Capital Management first reported a position in Biogen in Q4 2014 and held it in 19 quarters.
- Cadence Capital Management's Biogen position peaked at $3.28M in Q3 2016.
- 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.
Based on Cadence Capital Management's 13F filing for Q3 2019, filed 29 Oct 2019.